Skip to content

Do oral Lactobacillus tablets help in prevention of recurrent UTI in females

Does oral Lactobacillus therapy help in prevention of recurrent UTI as compared to oral antibiotic prophylaxis- A randomized controlled trial. - NIL

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/11/077444
Enrollment
96
Registered
2024-11-28
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N390- Urinary tract infection, site notspecified

Interventions

Intervention1: Oral Lactobacillus: Patients shall be given oral lactobacillus therapy in the form of tablets thrice daily for 1 week followed once daily for 3 months. Control Intervention1: Oral Antib

Sponsors

Aiims Bhubanesswar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients aged 18 years or above with culture-proven recurrent UTIs Written informed consent.

Exclusion criteria

Exclusion criteria: 1.Complicated cystitis 2.Uncomplicated pyelonephritis 3.A history of urologic abnormality or renal calculi 4.Recent sexually transmitted infections (STI) 5.History of recurrent Bacterial vaginosis 6.Risk factors for STI and human immunodeficiency virus (HIV) infection 7.Pregnancy or within 2 months of pregnancy 8.Lactation 9.Uncontrolled Diabetes (controlled would be enrolled) 10.Other immunocompromised states 11.Drug or alcohol abuse Abnormal pelvic examination results

Design outcomes

Primary

MeasureTime frame
To see the rate of symptomatic UTIs (clinical recurrences (CR)) during the 3 months of therapy, as reported by the patientTimepoint: at presentation at 1 month at 3 months

Secondary

MeasureTime frame
a)To measure the number of microbiologically confirmed symptomatic UTIs (microbiologic recurrences) during the 3 months of prophylaxis.Timepoint: at presentation at 1 month at 3 months;b)To compare the time to the first Microbiologic Recurrence (MR). An MR was defined as a UTI based on the combination of clinical symptoms and bacteriuria (103 CFU/mL bacteria in midstream urine).Timepoint: at presentation at 1 month at 3 months;c)The most common causative microorganism in Indian women.Timepoint: at presentation at 1 month at 3 months

Countries

India

Contacts

Public ContactDr Prasanna Ram

AIIMS

dr.praspr@gmail.com9686559576

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026